Tong Ren Tang Technologies Co (STU:TNG) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:TNG Tong Ren Tang Technologies Co Ltd STU:TNG
78 GF Score
Price €0.34
GF Value €0.55
! 5 Warning Signs
View Full Analysis

What is Tong Ren Tang Technologies Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

STU:TNG
78GF Score
Tong Ren Tang Technologies Co Ltd STU:TNG
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tong Ren Tang Technologies Co (STU:TNG) Overvalued in 2026?

Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued. The current stock price of €0.34 is trading 38.9% below its estimated GF Value™ of €0.55.

Key valuation signals for STU:TNG:

  • Dividends Received:
  • GF Value™: €0.55 vs. price of €0.34 (38.9% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the STU:TNG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tong Ren Tang Technologies Co Business Description

Other Exchanges TGRNF:USA01666:Hong Kong
Address No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
78GF Score

Get the complete analysis for STU:TNG

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.34
Price
€0.55
GF Value